352353-42-5

Basic information

• Product Name: acetic acid 8-[2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yloxy]-8,13,15-trioxo-7,9,17-trioxa-1,14-diaza-8λ⁵-phospha-tricyclo[10.3.1.1^2,5]heptadec-12(16)-en-4-yl ester
• CAS NO: 352353-42-5
• Molecular Weight: 902.849
• Mol File: 352353-42-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: acetic acid 8-[2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yloxy]-8,13,15-trioxo-7,9,17-trioxa-1,14-diaza-8λ⁵-phospha-tricyclo[10.3.1.1^2,5]heptadec-12(16)-en-4-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: acetic acid 8-[2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yloxy]-8,13,15-trioxo-7,9,17-trioxa-1,14-diaza-8λ⁵-phospha-tricyclo[10.3.1.1^2,5]heptadec-12(16)-en-4-yl ester(352353-42-5)
• EPA Substance Registry System: acetic acid 8-[2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yloxy]-8,13,15-trioxo-7,9,17-trioxa-1,14-diaza-8λ⁵-phospha-tricyclo[10.3.1.1^2,5]heptadec-12(16)-en-4-yl ester(352353-42-5)

Safety Data

• Hazardous Substances Data: 352353-42-5(Hazardous Substances Data)

Upstream product

• 352320-16-2 3'-O-acetyl-5'-O-(4,4'-dimethoxytrityl)-5-[2-(4,4'-dimethoxytrityloxy)ethyl]-2'-deoxyuridine 
• 352320-15-1 5'-O-(4,4'-dimethoxytrityl)-5-[2-(4,4'-dimethoxytrityloxy)ethyl]-2'-deoxyuridine 
• 90301-69-2 5-(2-chloroethyl)-1-(2-deoxy-3,5-di-O-p-toluoyl-β-D-erythro-pentofuranosyl)-1H,3H-pyrimidine-2,4-dione 
• 90301-60-3 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(2-hydroxyethyl)pyrimidine-2,4(1H,3H)-dione 
• 40615-39-2 5'-O-(4-4'-dimethoxytrityl)thymidine 
• 104655-84-7 5‘-O-dimethoxytrityl-2’-deoxyribothymidine 3‘-O-phosphorodiamidite 
• 352320-17-3 3'-O-acetyl-5-(2-hydroxyethyl)-2'-deoxyuridine 

Relevant articles and documents

Essential factors for stabilization of the predominant C3′-endo conformation in dinucleoside phosphotriester derivatives with cyclonucleotide bridge structures at the downstream 3′-position

This paper describes the synthesis of conformationally constrained dinucleoside cyclic phosphotriester derivatives and related compounds, such as Tpc3Um (2), Tpc3dU (3), Tpc2dU (4), pc3dU (16), and pc2dU (25), where c2 and c3 refer to ethylene and propyle